IW-3718 Investigator

Chattanooga, Tennessee 37421

0 studies enrolling now · 1 studies all time

What they study most

Gastroesophageal Reflux Disease

Studies at this site

• A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD) — Completed